Compare
AbbVie vs Cencora (ABBV vs COR)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year AbbVie (ABBV) returned +34.4% and Cencora (COR) -5.8%; so far this year the figures are +27.5% and -1.2%.
AbbVie is the larger company by market value, about 8.1 times the size of Cencora.
On trailing earnings, ABBV trades at 50.1 times and COR at 24.8 times.
Revenue grew +10.7% at ABBV and +5.1% at COR over the last year.
ABBV yields 2.38%. COR yields 0.72%.
Data as of the latest close. Not investment advice.
Relative performance
| ABBV | COR | |
|---|---|---|
| Price | $291.31 | $333.56 |
| 1-day | +1.07% | -1.80% |
| YTD | +27.49% | -1.24% |
| 1 year | +34.39% | -5.77% |
| 3 years | +104.47% | +78.16% |
| Market cap | $514.9B | $63.6B |
| P/E | 50.1 | 24.8 |
| P/S | 7.80 | 0.19 |
| P/B | — | 20.86 |
| Revenue growth | +10.70% | +5.10% |
| EPS growth | +340.20% | +38.30% |
| Gross margin % | 73.7 | 4.0 |
| Net margin % | 15.7 | 0.8 |
| ROE % | — | 86.0 |
| Debt / equity | — | 3.84 |
| FCF yield % | 3.7 | 6.4 |
| Dividend yield % | 2.38 | 0.72 |
| Beta | -0.03 | 0.00 |
| RSI (14) | 59.7 | 51.6 |
| Technical rating |